A
AEON Biopharma, Inc. (AEON)
ASE – Real vaqt narxi. Valyuta: USD
0.72
+0.03 (4.62%)
Yopilishda: Jun 26, 2026, 4:00 PM EDT
0.70
-0.02 (-2.47%)
Bozordan keyin: Jun 26, 2026, 7:36 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
ASE – Real vaqt narxi. Valyuta: USD
0.72
+0.03 (4.62%)
Yopilishda: Jun 26, 2026, 4:00 PM EDT
0.70
-0.02 (-2.47%)
Bozordan keyin: Jun 26, 2026, 7:36 PM EDT
Daromad taqsimoti ma'lumotlari hali hisoblanmagan.
No Data
Ushbu aksiya uchun yangiliklar yo'q.
| KO‘RSATKICH NOMI | KO‘RSATKICH | SANOAT O‘RTACHASI | 5 YILLIK TREND | BALL |
|---|---|---|---|---|
| Joriy likvidlik ko'rsatkichi | 0.99 | 6.05 | 6.0 | |
| Tezkor likvidlik nisbati | 0.99 | 5.63 | 6.0 | |
| Qarz/Kapital nisbati | N/A | 0.30 | 1.0 | |
| Qarz/Aktivlar nisbati | 0.30 | 1.04 | 7.0 | |
| Foiz to‘lov qoplami | N/A | -16.91 | 1.0 | |
| O‘rtacha ball | 4.2 | |||
| KO‘RSATKICH | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Jami daromad | N/A | N/A | N/A | N/A | N/A |
| Yalpi foyda | -68K | -99K | -97K | -78K | -78K |
| Operatsion daromad | -48M | -53M | -28M | -17M | -19M |
| Sof foyda | -53M | -385M | 42M | -39M | -60M |
| EBITDA | -48M | -53M | -28M | -17M | -19M |
| NOMI | KOEFF. | SANOAT | 5 YIL | BALL |
|---|---|---|---|---|
| Yalpi marja % | N/A | -11.73 | 1.0 | |
| Operatsion marja % | N/A | -24.60 | 1.0 | |
| Sof marja % | N/A | -172.20 | 1.0 | |
| EBITDA marja % | N/A | -201.27 | 1.0 | |
| Pul oqimi marja % | N/A | -156.39 | 1.0 | |
| O‘rtacha ball | 1.0 | |||
| Nomi | DAROMAD O'SISHI | EPS O‘SISHI | BALL |
|---|---|---|---|
| Joriy chorak | N/A | 45 | 5.5 |
| Keyingi chorak | N/A | 30.77 | 5.5 |
| Joriy yil | N/A | 73.42 | 5.5 |
| Keyingi yil | N/A | -2780 | 1.0 |
| O‘rtacha ball | 4.4 | ||
| NOMI | DAROMAD | SOF FOYDA | EPS | FCF | BALL |
|---|---|---|---|---|---|
| Chorak/Chorak | 999 | 68.24 | 94.47 | 44.06 | 10 |
| Yil/Yil | 999 | -229.65 | -112.71 | 66.69 | 5.5 |
| 3 yil o‘rtacha | 999 | -238.08 | 138.46 | 13.01 | 7.3 |
| 5 yil o‘rtacha | 999 | 45441.52 | N/A | -252.59 | 5.5 |
| O‘rtacha ball | 7.1 | ||||
Insufficient positive free cash flow for DCF analysis
| NOMI | JORIY | SANOAT | BALL |
|---|---|---|---|
| Dividend foizi | 0.00 | N/A | 1.0 |
| To'lov koeffitsienti | 0.00 | N/A | 1.0 |
| 5 yillik dividend o‘sishi | N/A | N/A | 1.0 |
| Dividend oshgan yillar | N/A | N/A | 1.0 |
| O‘rtacha ball | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NOMI | MASSHTAB | BALL |
|---|---|---|
| Bozor ulushi | Yo'q | 1.0 |
| Nomoddiy aktivlar | Yo'q | 1.0 |
| O'zgartirish xarajatlari | Yo'q | 1.0 |
| Tarmoq ta'siri | Yo'q | 1.0 |
| Masshtab ta'siri | Yo'q | 1.0 |
| O‘rtacha ball | 1.0 | |
Kompaniyaning naqd pul zahiralari $6.2M umumiy qarzdan $2.6M sezilarli darajada ko'p bo'lib, kuchli moliyaviy moslashuvchanlikni ta'minlaydi
Jami joriy aktivlar $6.6M jami joriy majburiyatlarni $6.7M zo'rg'a qoplaydi, bu cheklangan likvidlikni ko'rsatadi
Qarz/kapital nisbati (-0.2) tarmoq o'rtachasidan (0.3) sezilarli past bo'lib, ehtiyotkor moliyaviy boshqaruvni namoyish etadi
Foiz xarajatlari mavjud, ammo EBIT ma'lumotlari mavjud emas, bu potentsial rentabellik muammolarini ko'rsatadi
Salbiy erkin pul oqimi -$2.6M kompaniyaning qayta investitsiya qilish yoki qarzni to'lash qobiliyatini cheklaydi